{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T10:40:17Z","timestamp":1761734417384,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ejmg.2019.103764","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T12:06:13Z","timestamp":1568117173000},"page":"103764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A successful treatment of tadalafil in incontinentia pigmenti with pulmonary hypertension"],"prefix":"10.1016","volume":"63","author":[{"given":"Masanori","family":"Mizuno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Aso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimitsu","family":"Tsuzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Kitazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ohsuke","family":"Migita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isamu","family":"Hokuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmg.2019.103764_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2147\/TCRM.S134705","article-title":"Pulmonary hypertension and vasculopathy in incontinentia pigmenti: a case report","volume":"13","author":"Alshenqiti","year":"2017","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.ejmg.2019.103764_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2045894018793983","article-title":"A case of reversible pulmonary arterial hypertension associated with incontinentia pigmenti","volume":"8","author":"Atallah","year":"2018","journal-title":"Pulm Circ"},{"key":"10.1016\/j.ejmg.2019.103764_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.jp.7211250","article-title":"Unusual neonatal presentation of incontinentia pigmenti with persistent pulmonary hypertension of the newborn: a case report","volume":"25","author":"Godambe","year":"2005","journal-title":"J. Perinatol."},{"key":"10.1016\/j.ejmg.2019.103764_bib3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ajmg.a.30698","article-title":"Unilateral acheiria and fatal primary pulmonary hypertension in a girl with incontinentia pigmenti","volume":"135","author":"Hayes","year":"2005","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejmg.2019.103764_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/cvr\/cvt105","article-title":"Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354","volume":"99","author":"Hosokawa","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejmg.2019.103764_bib5","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1253\/circj.CJ-16-0423","article-title":"Neurovascular protective function of endothelial nitric oxide- recent advances","volume":"80","author":"Katusic","year":"2016","journal-title":"Circ. J."},{"key":"10.1016\/j.ejmg.2019.103764_bib6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejpn.2007.09.001","article-title":"Extensive cerebral infarction in the newborn due to incontinentia pigmenti","volume":"12","author":"Maingay-de Groof","year":"2008","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ejmg.2019.103764_bib7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/35013114","article-title":"Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium","volume":"405","author":"Smahi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejmg.2019.103764_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/hmg\/3.2.273","article-title":"The gene for the familial form of incontinentia pigmenti (IP2) maps to the distal part of Xq28","volume":"3","author":"Smahi","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmg.2019.103764_bib9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00246-012-0180-4","article-title":"Initial experience with tadalafil in pediatric pulmonary arterial hypertension","volume":"33","author":"Takatsuki","year":"2012","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.ejmg.2019.103764_bib10","first-page":"773","article-title":"[Cerebral complications of incontinentia pigmenti. A clinicopathological study of a case]","volume":"148","author":"Triki","year":"1992","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.ejmg.2019.103764_bib11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/ped.12831","article-title":"Fatal pulmonary arterial hypertension in an infant girl with incontinentia pigmenti","volume":"58","author":"Yasuda","year":"2016","journal-title":"Pediatr. Int."}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721218308097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721218308097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:48:48Z","timestamp":1761709728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721218308097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1769721218308097"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2019.103764","relation":{},"ISSN":["1769-7212"],"issn-type":[{"type":"print","value":"1769-7212"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A successful treatment of tadalafil in incontinentia pigmenti with pulmonary hypertension","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2019.103764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"103764"}}